Catherine C. Park

3.7k total citations
37 papers, 2.9k citations indexed

About

Catherine C. Park is a scholar working on Oncology, Cancer Research and Immunology and Allergy. According to data from OpenAlex, Catherine C. Park has authored 37 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Cancer Research and 14 papers in Immunology and Allergy. Recurrent topics in Catherine C. Park's work include Cell Adhesion Molecules Research (14 papers), Breast Cancer Treatment Studies (11 papers) and Cancer Cells and Metastasis (10 papers). Catherine C. Park is often cited by papers focused on Cell Adhesion Molecules Research (14 papers), Breast Cancer Treatment Studies (11 papers) and Cancer Cells and Metastasis (10 papers). Catherine C. Park collaborates with scholars based in United States, Japan and Italy. Catherine C. Park's co-authors include Mina J. Bissell, Mary Helen Barcellos‐Hoff, Joe W. Gray, Chong J. Park, Alvin Lo, Britta Weigelt, Jin‐Min Nam, Yasuhito Onodera, Hui Zhang and Maria G. Pallavicini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Catherine C. Park

36 papers receiving 2.9k citations

Peers

Countries citing papers authored by Catherine C. Park

Since Specialization

Citations

This map shows the geographic impact of Catherine C. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine C. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine C. Park more than expected).

Fields of papers citing papers by Catherine C. Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine C. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine C. Park. The network helps show where Catherine C. Park may publish in the future.

Co-authorship network of co-authors of Catherine C. Park

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine C. Park. A scholar is included among the top collaborators of Catherine C. Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine C. Park. Catherine C. Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma 2024 ·Advances in Radiation Oncology ·(unknown), (unknown), A. Patel, Gregor Krings, Yunn‐Yi Chen, (unknown), Rita A. Mukhtar, Michelle Melisko, Lisa Singer, Catherine C. Park, Nicolas D. Prionas	2
2	Exploring the Social Media Discussion of Breast Cancer Treatment Choices: Quantitative Natural Language Processing Study 2024 ·JMIR Cancer ·Daphna Y. Spiegel, (unknown), William Zhang, Travis Zack, (unknown), (unknown), Nicolas D. Prionas, Lisa Singer, Catherine C. Park, Julian C. Hong	1
3	American Radium Society Appropriate Use Criteria Postmastectomy Radiation Therapy: Executive Summary of Clinical Topics 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Manjeet Chadha, (unknown), Gary M. Freedman, Wendy Gao, Kelly K. Hunt, Catherine C. Park, (unknown), (unknown), Eleanor Walker, Julia S. Wong, Eleanor Harris	0
4	Matrix compliance permits NF-κB activation to drive therapy resistance in breast cancer 2021 ·The Journal of Experimental Medicine ·Allison P. Drain, Nastaran Zahir, Jason J. Northey, Hui Zhang, Po‐Jui Huang, Ori Maller, Johnathon N. Lakins, Xinmiao Yu, Jennifer L. Leight, Brenda Alston‐Mills, E. Shelley Hwang, Yunn‐Yi Chen, Catherine C. Park, Valerie M. Weaver	45
5	Residents-as-Teachers Curriculum for Radiation Oncology: A Targeted Needs Assessment 2021 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Horatio Thomas, David R. Raleigh, Lauren Boreta, Catherine C. Park, Steve Braunstein	3
6	Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin 2016 ·Breast Cancer Research and Treatment ·Marcia R. Campbell, Hui Zhang, (unknown), Ana Ruiz-Sáenz, (unknown), (unknown), Dhara N. Amin, Deepika Ahuja, Mark M. Moasser, Catherine C. Park	15
7	TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy 2015 ·Cancer Immunology Research ·Stephen L. Shiao, Brian Ruffell, David G. DeNardo, Bruce Faddegon, Catherine C. Park, Lisa M. Coussens	207
8	ACR Appropriateness Criteria® Ductal Carcinoma in Situ. 2015 ·PubMed ·Seth Kaufman, Eleanor Harris, Lisa Bailey, Manjeet Chadha, Sharon C. Dutton, Gary M. Freedman, Sharad Goyal, Michele Y. Halyard, Kathleen C. Horst, (unknown), Catherine C. Park, W. Warren Suh, Deborah Toppmeyer, Jennifer Zook, Bruce G. Haffty	15
9	NF-κB Regulates Radioresistance Mediated By β1-Integrin in Three-Dimensional Culture of Breast Cancer Cells 2013 ·Cancer Research ·Kazi Mokim Ahmed, Hui Zhang, Catherine C. Park	75
10	β1 Integrin Targeting Potentiates Antiangiogenic Therapy and Inhibits the Growth of Bevacizumab-Resistant Glioblastoma 2013 ·Cancer Research ·W. Shawn Carbonell, Michael DeLay, Arman Jahangiri, Catherine C. Park, Manish K. Aghi	139
11	MRI Enhancement in Stromal Tissue Surrounding Breast Tumors: Association with Recurrence Free Survival following Neoadjuvant Chemotherapy 2013 ·PLoS ONE ·Ella F. Jones, Sumedha P. Sinha, David C. Newitt, Catherine Klifa, John Kornak, Catherine C. Park, Nola M. Hylton	41
12	Increasing the Time to Expander-Implant Exchange after Postmastectomy Radiation Therapy Reduces Expander-Implant Failure 2012 ·Plastic & Reconstructive Surgery ·Anne Warren Peled, Robert D. Foster, Laura J. Esserman, Catherine C. Park, E. Shelley Hwang, Barbara Fowble	75
13	β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib 2011 ·Breast Cancer Research ·Catherine Huang, Catherine C. Park, Susan G. Hilsenbeck, (unknown), Mothaffar F. Rimawi, Yen-Chao Wang, Jiang Shou, Mina J. Bissell, C. Kent Osborne, Rachel Schiff	143
14	Breast Cancer Cells in Three-dimensional Culture Display an Enhanced Radioresponse after Coordinate Targeting of Integrin α5β1 and Fibronectin 2010 ·Cancer Research ·Jin‐Min Nam, Yasuhito Onodera, Mina J. Bissell, Catherine C. Park	168
15	HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment 2009 ·Breast Cancer Research and Treatment ·Britta Weigelt, Alvin Lo, Catherine C. Park, Joe W. Gray, Mina J. Bissell	274
16	β1 integrin targeting to enhance radiation therapy 2009 ·International Journal of Radiation Biology ·(unknown), Yoonsun Chung, Howard Hsu, Catherine C. Park	46
17	High Mammographic Breast Density Is Independent Predictor of Local But Not Distant Recurrence After Lumpectomy and Radiotherapy for Invasive Breast Cancer 2008 ·International Journal of Radiation OncologyBiologyPhysics ·Catherine C. Park, (unknown), Karen Chew, Dan H. Moore, Karla Kerlikowske	54
18	β1 Integrin Inhibitory Antibody Induces Apoptosis of Breast Cancer Cells, Inhibits Growth, and Distinguishes Malignant from Normal Phenotype in Three Dimensional Cultures and In vivo 2006 ·Cancer Research ·Catherine C. Park, Hui Zhang, Maria G. Pallavicini, Joe W. Gray, Frederick L. Baehner, Chong J. Park, Mina J. Bissell	279
19	Systemic Metastasis in Glioblastoma May Represent the Emergence of Neoplastic Subclones 2000 ·Journal of Neuropathology & Experimental Neurology ·Catherine C. Park, Christian Hartmann, Rebecca D. Folkerth, Jay S. Loeffler, Patrick Y. Wen, Howard A. Fine, Peter McL. Black, Timothy D. Shafman, David N. Louis	56
20	The influence of the microenvironment on the malignant phenotype 2000 ·Molecular Medicine Today ·Catherine C. Park, Mina J. Bissell, Mary Helen Barcellos‐Hoff	309

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact